Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) announces a share repurchase program. Under the program, the company will repurchase 2,400,000 shares, representing 3.17% of its issued share capital, for ¥8,901.6 million. The shares will be repurchased at a price of ¥3,709 per share.

The purpose of the program is to improve capital efficiency and return greater profits to shareholders, as well as to implement a flexible capital policy that responds to changes in the business environment. The program will run until May 24, 2024. As of February 29, 2024, the company had 75,772,743 shares issued (excluding treasury stock) and 9,392,152 shares in treasury.